Skip to content

Oruka Therapeutics, Inc. ORKA Common Stock Shares Issued

Common Stock Shares Issued at other companies

Arcutis Biotherapeutics, Inc. logo
Arcutis Biotherapeutics, Inc.ARQT
125M+5.0%
Immunovant, Inc. logo
Immunovant, Inc.IMVT
203.3M+38.1%
Arcus Biosciences logo
Arcus BiosciencesRCUS
125.5M+18.5%
ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
Spyre Therapeutics, Inc. logo
Spyre Therapeutics, Inc.SYRE
Incyte logo
IncyteINCY

Other financials

Income statement

See full
Revenue-
Operating income-$36.4M-45.2%
Net income-$31.8M-51.5%
EPS (diluted)-$0.46+93.4%

Balance sheet

See full
Cash & equivalents$49.5M-40.7%
Total debt$1.8M+90.8%
Total equity$486.7M+33.4%
Total assets$504.5M+33.8%

Cash flow

See full
Operating cash flow-$23.6M-13.0%
CapEx$73.0K+462%
Free cash flow-$23.7M-13.3%

Valuation

See full
Market cap$5.03B+533%

Returns & leverage

See full
Return on equity-27.3%-11.1pp
Debt / equity0.0×
Current ratio23.8×-6.3×

Where this comes from

Reported directly by Oruka Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesIssued.

The official record: Oruka Therapeutics, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Oruka Therapeutics, Inc.'s common stock shares issued.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Oruka Therapeutics, Inc.'s common stock shares issued?
Oruka Therapeutics, Inc. (ORKA) reported common stock shares issued of 50.2M in Q1 2026.
How has Oruka Therapeutics, Inc.'s common stock shares issued changed year-over-year?
Oruka Therapeutics, Inc.'s common stock shares issued increased by 34.0% year-over-year, from 37.4M to 50.2M.
What does common stock shares issued mean?
The total number of shares that have been authorized and distributed by the corporation since its inception. This includes shares held by the public (outstanding) as well as any shares that the company has repurchased and holds in its treasury. It represents the historical volume of equity capital creation.